Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of British Columbia
$27,000.00
Investigating sex differences in the effect of APOE genotype on lipid trajectories and cognitive decline in North American biobanks
EF 2025-26
Résumé
Dementia is a progressive disease that affects memory, thinking, and daily activities. Females and people who carry the APOE4 gene are at the highest risk for dementia, but we still do not fully understand why. APOE is involved in many different functions in the body, one of which is to transport and break down cholesterol. There are three forms of APOE: APOE2, APOE3, and APOE4. APOE4 is the least efficient at transporting cholesterol which suggests that one of the ways APOE4 increases dementia risk is by disrupting cholesterol processing. Sex hormones also regulate cholesterol. At most life stages, females have higher levels of ‘good cholesterol’ and lower levels of ‘bad cholesterol’ than males, but they lose this advantage after menopause when estrogen levels decline. High cholesterol during middle age is a known and modifiable risk factor for dementia, but we still do not know whether APOE4 increases dementia risk through its effects on cholesterol, or whether this relationship differs between males and females. The goal of my project is to understand how APOE4 affects cholesterol across the lifetime for each sex and how this corresponds to dementia risk. The Canadian Longitudinal Study on Aging is collecting genetic, demographic, lifestyle, and clinical data from 26,000 Canadians between the ages of 45 and 85. Participants were recruited in 2010-2012, with follow-ups occurring every three years until 2033 or death. Using computational and statistical methods, I will study how APOE, cholesterol, and sex interact over time to influence dementia risk. This work will help us assess how cholesterol-lowering strategies can help females and APOE4 carriers reduce their risk, and when in life these interventions will be most effective.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
572655
Name
Gunderson Sara
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating sex differences in the effect of APOE genotype on lipid trajectories and cognitive decline in North American biobanks
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Apolipoprotein E; Biobanks; Cognitive Decline; Dementia; Genetic Epidemiology; Lipids; Sex Differences
Abstract
Dementia is a progressive disease that affects memory, thinking, and daily activities. Females and people who carry the APOE4 gene are at the highest risk for dementia, but we still do not fully understand why. APOE is involved in many different functions in the body, one of which is to transport and break down cholesterol. There are three forms of APOE: APOE2, APOE3, and APOE4. APOE4 is the least efficient at transporting cholesterol which suggests that one of the ways APOE4 increases dementia risk is by disrupting cholesterol processing. Sex hormones also regulate cholesterol. At most life stages, females have higher levels of ‘good cholesterol’ and lower levels of ‘bad cholesterol’ than males, but they lose this advantage after menopause when estrogen levels decline. High cholesterol during middle age is a known and modifiable risk factor for dementia, but we still do not know whether APOE4 increases dementia risk through its effects on cholesterol, or whether this relationship differs between males and females. The goal of my project is to understand how APOE4 affects cholesterol across the lifetime for each sex and how this corresponds to dementia risk. The Canadian Longitudinal Study on Aging is collecting genetic, demographic, lifestyle, and clinical data from 26,000 Canadians between the ages of 45 and 85. Participants were recruited in 2010-2012, with follow-ups occurring every three years until 2033 or death. Using computational and statistical methods, I will study how APOE, cholesterol, and sex interact over time to influence dementia risk. This work will help us assess how cholesterol-lowering strategies can help females and APOE4 carriers reduce their risk, and when in life these interventions will be most effective.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Gunderson, Sara
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~